21-004683-0001 1200mg delta8+cbg oil - chocolate lot

9
12423 NE Whitaker Way Portland, OR 97230 503-254-1794 Report Number: Report Date: ORELAP#: 05/04/2021 OR100028 10:40 Received: 04/28/21 Purchase Order: 21-004683/D02.R00 Product identity: 1200mg Delta8+CBG Oil - Chocolate Lot 040921.D8MC.PK1 Client/Metrc ID: . Customer: 04/26/21 09:30 Sample Date: 21-004683-0001 Laboratory ID: Pure Kana Summary Potency: CBD-Total <LOQ THC-Total <LOQ (Reported in percent of total sample) 8-THC CBG CBN Analyte Result (%) 3.41 Δ8-THC 0.711 CBG 0.00381 CBN Page 1 of 9 www.columbialaboratories.com Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance plan unless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unless prior arrangements have been made. Testing in accordance with: OAR 333-007-0430

Upload: others

Post on 22-Mar-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Product identity: 1200mg Delta8+CBG Oil - Chocolate Lot 040921.D8MC.PK1Client/Metrc ID: .

Customer:

04/26/21 09:30Sample Date:21-004683-0001Laboratory ID:

Pure Kana

SummaryPotency:

CBD-Total <LOQ

THC-Total <LOQ

(Reported in percent of total sample)

∆8-THC

CBGCBN

Analyte Result (%)3.41Δ8-THC†

0.711CBG†

0.00381CBN

Page 1 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Customer: Pure KanaUnited States of America (USA)

Product identity:

04/26/21 09:30Sample Date:21-004683-0001Laboratory ID:

Client/Metrc ID: .

NoEvidence of Cooling:19.5 °CTemp:

Sample ResultsBatch: 2103911Potency Method J AOAC 2015 V98-6 (mod) Analyze: 4/29/21 6:40:00 PMUnits %

Analyte AsReceived

Dryweight

LOQ Notes

< LOQCBC 0.0033< LOQCBC-A† 0.0033< LOQCBC-Total† 0.0062< LOQCBD 0.0033< LOQCBD-A 0.0033< LOQCBD-Total 0.0062< LOQCBDV† 0.0033< LOQCBDV-A† 0.0033< LOQCBDV-Total† 0.00620.711CBG† 0.0033< LOQCBG-A† 0.00330.711CBG-Total 0.0062< LOQCBL† 0.00330.00381CBN 0.00333.41Δ8-THC† 0.0330< LOQΔ9-THC 0.0033< LOQTHC-A 0.0033< LOQTHC-Total 0.0062< LOQTHCV† 0.0033< LOQTHCV-A† 0.0033< LOQTHCV-Total† 0.00624.12Total Cannabinoids†

∆8-THC

CBGCBN

Page 2 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

1200mg Delta8+CBG Oil - Chocolate Lot 040921.D8MC.PK1

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

These test results are representative of the individual sample selected and submitted by the client.Abbreviations Limits: Action Levels per OAR-333-007-0400, OAR-333-007-0210, OAR-333-007-0220Limit(s) of Quantitation (LOQ): The minimum levels, concentrations, or quantities of a target variable (e.g., targetanalyte) that can be reported with a specified degree of confidence.

† = Analyte not NELAP accredited.

Units of Measure % = Percentage of sample% wt = µg/g divided by 10,000

Derrick TannerGeneral Manager

Approved Signatory

Page 3 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Client signed and returned COC via email. 4/28/2021 -PG

Page 4 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

21-004683

1

2

1 2Original COC. See attached for signature. 4/28/2021 -PG

Page 5 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

21-004683

2 2

Page 6 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Revision #: 0.00 Control : CFL-D06

Revision Date: 05/31/2019 Effective Date: 05/31/2019

J AOAC 2015 V98-6 Batch ID:Laboratory Control SampleAnalyte Spike Units % Rec Evaluation NotesCBDV-A 0.01 96.7 85.0 - 115 Acceptable

CBDV 0.01 99.2 85.0 - 115 Acceptable

CBD-A 0.01 98.8 85.0 - 115 Acceptable

CBG-A 0.01 97.3 85.0 - 115 Acceptable

CBG 0.01 100 85.0 - 115 Acceptable

CBD 0.01 111 85.0 - 115 Acceptable

THCV 0.01 100.0 85.0 - 115 Acceptable

THCVA 0.01 92.5 85.0 - 115 Acceptable

CBN 0.01 104 85.0 - 115 Acceptable

THC 0.01 100 85.0 - 115 Acceptable

D8THC 0.01 99.6 85.0 - 115 Acceptable

CBL 0.01 92.1 85.0 - 115 Acceptable

CBC 0.01 112 85.0 - 115 Acceptable

THCA 0.01 96.7 85.0 - 115 Acceptable

CBCA 0.01 96.4 85.0 - 115 Acceptable

Method BlankAnalyte LOQ Evaluation NotesCBDV-A 0.003 < Acceptable

CBDV 0.003 < Acceptable

CBD-A 0.003 < Acceptable

CBG-A 0.003 < Acceptable

CBG 0.003 < Acceptable

CBD 0.003 < Acceptable

THCV 0.003 < Acceptable

THCVA 0.003 < Acceptable

CBN 0.003 < Acceptable

THC 0.003 < Acceptable

D8THC 0.003 < Acceptable

CBL 0.003 < Acceptable

CBC 0.003 < Acceptable

THCA 0.003 < Acceptable

CBCA 0.003 < Acceptable

Abbreviations

ND - None Detected at or above MRL

RPD - Relative Percent Difference

LOQ - Limit of Quantitation

Units of Measure:

% - Percent

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

Result

0.00964

0.0100

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

<LOQ

0.003

%

%

0.003

0.003

%

%

%

0.003

0.003

0.003

Laboratory Quality Control Results2103874/2103911

Limits

%

%

%

%

%

%

%

%

%

0.00992

0.00967

Result

0.0104

0.00925

0.01000

0.0111

0.0100

0.00973

0.00988

%

Limits

%

%

0.00967

0.0112

0.00921

0.00996

%

%

%

0.003

%

%

%

%

%

%

Units

0.003

0.003

0.003

0.003

0.003

0.003

0.003

0.003

%

%

%

%

Page 7 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Revision #: 0.00 Control : CFL-D06

Revision Date: 05/31/2019 Effective Date: 05/31/2019

Laboratory Quality Control ResultsJ AOAC 2015 V98-6 Batch ID:Sample Duplicate Sample ID:

Analyte Result Org. Result LOQ Units RPD Evaluation NotesCBDV-A <LOQ <LOQ 0.003 NA < Acceptable

CBDV 0.00950 0.00985 0.003 3.59 < Acceptable

CBD-A <LOQ <LOQ 0.003 NA < Acceptable

CBG-A <LOQ <LOQ 0.003 NA < Acceptable

CBG 0.0602 0.0609 0.003 1.23 < Acceptable

CBD 2.21 2.10 0.003 5.02 < Acceptable

THCV <LOQ <LOQ 0.003 NA < Acceptable

THCVA <LOQ <LOQ 0.003 NA < Acceptable

CBN 0.0184 0.0187 0.003 1.57 < Acceptable

THC 0.0689 0.0700 0.003 1.60 < Acceptable

D8THC <LOQ <LOQ 0.003 NA < Acceptable

CBL 0.00757 0.00672 0.003 11.8 < Acceptable

CBC 0.0792 0.0810 0.003 2.23 < Acceptable

THCA <LOQ <LOQ 0.003 NA < Acceptable

CBCA <LOQ <LOQ 0.003 NA < Acceptable

Abbreviations

ND - None Detected at or above MRL

RPD - Relative Percent Difference

LOQ - Limit of Quantitation

NA - Calculation Not Applicable given non-numerical results

Units of Measure:

% - Percent

% 20

% 20

% 20

%

21-004681-0001

% 20

% 20

20

2103874/2103911

% 20

Limits

% 20

% 20

% 20

% 20

20

% 20

%

% 20

% 20

Page 8 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:Report Date:ORELAP#:

05/04/2021OR100028

10:40Received: 04/28/21Purchase Order:

21-004683/D02.R00

Code ExplanationQ Matrix interferences affecting spike or surrogate recoveries.Q1 Quality control result biased high. Only non-detect samples reported.Q2 Quality control outside QC limits. Data considered estimate.Q3 Sample concentration greater than four times the amount spiked.Q4 Non-homogenous sample matrix, affecting RPD result and/or % recoveries.Q5 Spike results above calibration curve.Q6 Quality control outside QC limits. Data acceptable based on remaining QC.R Relative percent difference (RPD) outside control limit.R1 RPD non-calculable, as sample or duplicate results are less than five times the LOQ.R2 Sample replicates RPD non-calculable, as only one replicate is within the analytical range.LOQ1 Quantitation level raised due to low sample volume and/or dilution.LOQ2 Quantitaion level raised due to matrix interference.B Analyte detected in method blank, but not in associated samples.B1 The sample concentration is greater than 5 times the blank concentration.B2 The sample concentration is less than 5 times the blank concentration.

Explanation of QC Flag Comments:

Page 9 of 9www.columbialaboratories.com

Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430